QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
BEACON - ABC in Recurrent Platinum Resistant HGSOC
- Status
- UNKNOWN
- Phase
- PHASE2
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Two Chemotherapy Regimens Plus or Minus Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Refractive Error and Biometry in Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
- Status
- COMPLETED
- Phase
- PHASE1
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1